rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Richard Pulik

CFO

Company insider

Files Form 4 as: CFO, Roivant Sciences.

Every Form 4 they filed

In numbers

Trades disclosed
71
Buys
0
Sells
2
Bought
$0
Sold
$9.1M
Companies
1
Companies where not an officer
0
First trade
20 Oct 2021
Last trade
20 Sep 2026
Last filed
22 Sep 2026

Companies traded

Where they are an officer
ROIV Roivant SciencesOfficer · Biotechnology · last 20 Sep 20260 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Sep 2026filed 22 Sep 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$85K2,129 at $39.77filing
20 Sep 2026filed 22 Sep 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$85K2,129 at $39.77filing
20 Aug 2026filed 24 Aug 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$212K5,749 at $36.84filing
20 Aug 2026filed 24 Aug 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$212K5,749 at $36.84filing
20 Jun 2026filed 23 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$67K2,129 at $31.43filing
20 Jun 2026filed 23 Jun 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$67K2,129 at $31.43filing
20 May 2026filed 22 May 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$615K18,962 at $32.41filing
20 May 2026filed 22 May 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$615K18,962 at $32.41filing
20 Apr 2026filed 22 Apr 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—60,644 at $0.00filing
20 Apr 2026filed 22 Apr 2026ROIV Roivant Sciencesoption or derivative · BiotechnologySEC FORM 4 Code A—84,026 at $0.00filing
20 Apr 2026filed 22 Apr 2026ROIV Roivant Sciencesoption or derivative · BiotechnologySEC FORM 4 Code A—84,026 at $0.00filing
20 Apr 2026filed 22 Apr 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code A—60,644 at $0.00filing
20 Mar 2026filed 24 Mar 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$43K1,546 at $27.70filing
20 Mar 2026filed 24 Mar 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$43K1,546 at $27.70filing
20 Feb 2026filed 24 Feb 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$27K1,000 at $27.15filing
20 Feb 2026filed 24 Feb 2026ROIV Roivant SciencesBiotechnologySEC FORM 4 Code F$27K1,000 at $27.15filing
23 Dec 2025filed 29 Dec 2025ROIV Roivant Sciencesoption or derivative · BiotechnologySEC FORM 4 Code M—260,000 at $0.00filing
23 Dec 2025filed 29 Dec 2025ROIV Roivant SciencesBiotechnologySEC FORM 4 Code M$1.0M260,000 at $3.85filing
23 Dec 2025filed 29 Dec 2025ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$5.8M260,000 at $22.45filing
23 Dec 2025filed 29 Dec 2025ROIV Roivant SciencesBiotechnologySEC FORM 4 Sold$3.3M146,731 at $22.39filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Epperly Melissa BDirector · Director at Roivant Sciences, filing Form 4 there in the last year
Frank TortiPresident and Vant Chair · President and Vant Chair at Roivant Sciences, filing Form 4 there in the last year
Eric VenkerChief Executive Officer · President & Immunovant CEO at Roivant Sciences, filing Form 4 there in the last year
Matthew GlineCEO · CEO at Roivant Sciences, filing Form 4 there in the last year
Mayukh SukhatmePresident & CIO · President & CIO at Roivant Sciences, filing Form 4 there in the last year
Meghan FitzgeraldDirector · Also traded ROIV in the last 90 days